Dudley & Shanley Inc. Lowers Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Dudley & Shanley Inc. trimmed its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 0.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 461,381 shares of the company’s stock after selling 240 shares during the period. Ryan Specialty accounts for approximately 4.6% of Dudley & Shanley Inc.’s portfolio, making the stock its 7th largest holding. Dudley & Shanley Inc. owned 0.18% of Ryan Specialty worth $29,602,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the company. GAMMA Investing LLC raised its holdings in shares of Ryan Specialty by 38.1% in the 4th quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. JPMorgan Chase & Co. grew its position in Ryan Specialty by 107.5% in the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after acquiring an additional 238,064 shares in the last quarter. Principal Financial Group Inc. increased its stake in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock valued at $56,545,000 after acquiring an additional 509,548 shares during the last quarter. Tidal Investments LLC raised its position in Ryan Specialty by 30.4% during the third quarter. Tidal Investments LLC now owns 12,255 shares of the company’s stock valued at $814,000 after purchasing an additional 2,858 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new stake in Ryan Specialty during the third quarter worth about $193,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00. Following the sale, the director now owns 50,400 shares in the company, valued at approximately $3,284,568. This trade represents a 40.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at $884,236.54. The trade was a 54.42 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 126,936 shares of company stock worth $8,536,282 in the last quarter. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Up 0.8 %

NYSE RYAN traded up $0.51 during trading hours on Friday, reaching $63.14. 193,154 shares of the company’s stock traded hands, compared to its average volume of 469,664. Ryan Specialty Holdings, Inc. has a 52-week low of $41.65 and a 52-week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a 50-day simple moving average of $69.11 and a 200 day simple moving average of $65.36. The firm has a market cap of $16.53 billion, a PE ratio of 82.00, a PEG ratio of 1.52 and a beta of 0.67.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. The firm had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 EPS. Sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Wells Fargo & Company increased their price objective on Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price target for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. Finally, Bank of America lifted their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Ryan Specialty currently has a consensus rating of “Hold” and a consensus price target of $73.50.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.